Abstract
A human macrophage-like line, designated 2MAC, has been established from peripheral blood. 2MAC expresses a number of lineage-specific markers as well as a broad array of intercellular adhesion molecules. In particular, 2MAC expresses CD16/Fc gammaRIII, the low-affinity Fc receptor for IgG, as well as high levels of HLA class I and class II. Consistent with this macrophage assignment, we present evidence that 2MAC expresses the macrophage form of CD16, namely, Fc gammaRIIIA/gamma. By several criteria also applicable to signal transducing NK CD16 and T cell CD3/TCR complexes, including modulation from the cell surface and Ca2+ mobilization in response to ligation by specific monoclonal antibody, CD16 expressed by 2MAC is functional. Ligation of 2MAC HLA class II, but not HLA class I, by specific mAb induces an increase in free cytoplasmic Ca2+ concentration ([Ca2+]i). This Ca2+ flux appears to be physiologically relevant, as ligation of HLA-DR, but not HLA class I, by mAb results in the efficient, Ca2+ mobilization-dependent induction of tissue factor by 2MAC. 2MAC, therefore, should prove useful for studying signal transduction through macrophage CD16 and HLA class II.
References
May 1, 1992·The Journal of Experimental Medicine·U WirthmuellerJ V Ravetch
Mar 19, 1992·The New England Journal of Medicine·B Furie, B C Furie
Feb 1, 1990·Human Immunology·W Y YuR W Karr
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·F D HowardE L Reinherz
Apr 1, 1991·European Journal of Immunology·J H PhillipsL L Lanier
Mar 8, 1991·Cell·C Romeo, B Seed
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P AndersonS F Schlossman
May 17, 1990·Nature·Y ShimizuS Shaw
Sep 1, 1985·The Journal of Clinical Investigation·B S Schwartz
Oct 4, 1988·Journal of Immunological Methods·M G LowP W Kincade
Oct 19, 1989·Nature·M L Dustin, T A Springer
Aug 1, 1989·The Journal of Experimental Medicine·J V Ravetch, B Perussia
Oct 26, 1989·Nature·C RaJ P Kinet
Dec 22, 1989·Science·M L HibbsJ P Kinet
Dec 14, 1989·Nature·L L LanierJ H Phillips
Dec 14, 1989·Nature·T Kurosaki, J V Ravetch
Feb 1, 1989·The Journal of Experimental Medicine·M A CassatellaB Perussia
Aug 1, 1989·Human Immunology·A Kolstad, K Hannestad
Jan 1, 1986·Annual Review of Immunology·A WeissJ Stobo
Feb 1, 1988·The Journal of Experimental Medicine·S B Clarkson, P A Ory
Jun 9, 1988·Nature·D Simmons, B Seed
Jun 16, 1988·Nature·T W HuizingaP A Tetteroo
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A M WeissmanR D Klausner
Jan 1, 1988·Annual Review of Biochemistry·D Kappes, J L Strominger
Nov 1, 1988·Thrombosis Research·J H MorrisseyT S Edgington
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D P DialynasJ L Strominger
Nov 1, 1985·Cell·L E SamelsonR D Klausner
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D A CantrellM J Crumpton
Dec 1, 1985·The Journal of Clinical Investigation·S A Gregory, T S Edgington
Feb 1, 1983·The Journal of Experimental Medicine·S C MeuerE L Reinherz
May 1, 1983·Molecular and Cellular Biology·P GunningL Kedes
Jan 1, 1994·Advances in Immunology·L MorettaA Moretta
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·J G Park, A D Schreiber
Jan 1, 1994·Annual Review of Immunology·P Cresswell
Jan 1, 1994·Annual Review of Immunology·A C ChanA Weiss
Jan 1, 1993·Advances in Immunology·B L KotzinP Marrack
Jan 1, 1996·Advances in Immunology·A Billiau
Apr 1, 1997·Immunology·D P DialynasJ Yu